QA: Reviva Pharmaceuticals Holdings INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001742927_2024_Reviva_Pharmaceuticals_Holdings_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001742927, Reviva Pharmaceuticals Holdings INC

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 23,700,388
4 LiabilitiesCurrent 17,175,017
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 806,655
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,083,819
9 ResearchAndDevelopmentExpense 31,419,817
10 remainder_Expenses 16,949
11 remainder_Revenues 0
12 remainder_NetIncome 259,748
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 23,700,388
1 Liabilities 17,981,672
2 Expenses 39,520,585
3 Revenues 0
4 StockholdersEquity 5,718,716
5 NetIncome -39,260,837
6 ComprehensiveNetIncome -39,260,837
7 BaseVar 40,731,196
8 EconomicCapitalRatiobeforeLimitedLiability -1.29
9 EconomicCapitalRatio 1.24

Edgar->Model Mapping

Feature Distribution

Change over Time